M&A / Deals

Eli Lilly maintains M&A streak with $202m Engage Bio buyout

Pharmaceutical Technology

Eli Lilly's takeover of Engage Bio marks the seventh acquisition for the big pharma since the start of 2026.

Read full story

pharminent May 21, 2026 (Last updated: May 21, 2026)

Pharmaceutical Technology

Eli Lilly’s takeover of Engage Bio marks the seventh acquisition for the big pharma since the start of 2026.

Read full story